North America Apixaban Prices Movement Q2:

Apixaban Prices in USA:

In the USA, Apixaban Prices averaged 44,617 USD/MT in June 2025, continuing a steady upward trend. Strong demand for cardiovascular therapies, rising API and compliance costs, and consistent healthcare utilization supported prices. Although generics tempered volatility, stable supply chains reinforced firmness, reflecting controlled increases aligned with input costs and therapeutic consumption patterns.

Get the Real-Time Prices Analysis: https://www.imarcgroup.com/apixaban-pricing-report/requestsample

Note: The analysis can be tailored to align with the customer's specific needs.

APAC Apixaban Prices Movement Q2:

Apixaban Prices in China:

In China, apixaban stood at 24,295 USD/MT in June 2025, extending its growth momentum. Cardiovascular treatment demand drove robust API procurement, while limited competition among domestic producers sustained market strength. Supply remained consistent, though rising fermentation input costs added slight upward pressure. Overall, pricing reflected steady demand and controlled supply-side conditions across the quarter.

Apixaban Prices in India:

In India, apixaban prices averaged 30,369 USD/MT in June 2025, showing moderate firmness. Steady demand from hospitals and specialty clinics sustained consumption, while APIs sourced locally and from China ensured supply stability. Currency fluctuations and elevated formulation expenses added mild upward pressure, with overall trends reflecting balanced supply assurance and consistent downstream demand across the market.

Apixaban Prices in Korea:

In Korea, apixaban settled at 43,946 USD/MT in June 2025, remaining stable to slightly firm. Consistent healthcare demand, reliance on imported APIs, and expanded therapeutic approvals reinforced pricing. Early domestic generics introduced mild competition but had limited impact. Dependable supply chains and steady utilization shaped a resilient market trend, ensuring stability throughout the second quarter.

Regional Analysis: The price analysis can be extended to provide detailed Apixaban price information for the following list of countries.

China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Europe Apixaban Prices Movement Q2:

Apixaban Prices in Germany:

In Germany, apixaban reached 55,269 USD/MT in June 2025, maintaining resilience. Stable demand from advanced healthcare systems, combined with patent protections and limited generics, supported firm prices. API fermentation costs and delays in generic availability reinforced pricing strength. Hospital and retail distribution showed consistent procurement, minimizing volatility and sustaining a steady pricing environment throughout the quarter.

Regional Analysis: The price analysis can be expanded to include detailed Apixaban price data for a wide range of European countries, such as Germany, France, the United Kingdom, Italy, Spain, Russia, Turkey, the Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, the Czech Republic, Portugal, and Greece, along with other European nations.

Purchase Options: https://www.imarcgroup.com/checkout?id=22910&method=1925

• Biannual Updates: For 2 Deliverables, Billed Annually
• Quarterly Updates: For 4 Deliverables, Billed Annually
• Monthly Updates: For 12 Deliverables, Billed Annually

We Also Provide News and Historical Data of Apixaban

• Historical Data: Comprehensive historical pricing and market trends.
• Quarterly Analysis: Detailed insights into price fluctuations and market dynamics.
• Regional and Global Data: Coverage of key markets and their performance.
• Forecast Comparisons: Historical data paired with future market projections.
• Customizable Reports: Tailored analysis to meet specific business needs.

Factors Affecting Apixaban Prices:

Demand-Side Factors:

• Strong demand from cardiovascular and stroke prevention therapies.
• Expanding therapeutic approvals supporting wider usage.
• Steady healthcare utilization in hospitals and specialty clinics.

Supply-Side Factors:

• Dependence on imported APIs and raw materials.
• Rising API production and formulation costs.
• Limited competition in some regions, though generics added modest pressure.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=22910&flag=C

Key Coverage:

• Market Analysis
• Market Breakup by Region
• Demand Supply Analysis by Type
• Demand Supply Analysis by Application
• Demand Supply Analysis of Raw Materials
• Price Analysis
  • Spot Prices by Major Ports
  • Price Breakup
  • Price Trends by Region
  • Factors influencing the Price Trends
• Market Drivers, Restraints, and Opportunities
• Competitive Landscape
• Recent Developments
• Global Event Analysis

How IMARC Pricing Database Can Help

The latest IMARC Group study, “Apixaban Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data 2025 Edition,” presents a detailed analysis of Apixaban price trend, offering key insights into global Apixaban market dynamics. This report includes comprehensive price charts, which trace historical data and highlights major shifts in the market.

The analysis delves into the factors driving these trends, including raw material costs, production fluctuations, and geopolitical influences. Moreover, the report examines Apixaban demand, illustrating how consumer behaviour and industrial needs affect overall market dynamics. By exploring the intricate relationship between supply and demand, the prices report uncovers critical factors influencing current and future prices.

About Us:

IMARC Group is a global management consulting firm that provides a comprehensive suite of services to support market entry and expansion efforts. The company offers detailed market assessments, feasibility studies, regulatory approvals and licensing support, and pricing analysis, including spot pricing and regional price trends. Its expertise spans demand-supply analysis alongside regional insights covering Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa. IMARC also specializes in competitive landscape evaluations, profiling key market players, and conducting research into market drivers, restraints, and opportunities. IMARC’s data-driven approach helps businesses navigate complex markets with precision and confidence.

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145